Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03063047 · ClinicalTrials.gov registry record · NA
CSD1603: A Crossover Study to Evaluate the Exposure to "Tar" and Nicotine From 100s Menthol Cigarette Products
A NA study, sponsored by RAI Services Company.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT03063047 is a NA study that has completed, run by RAI Services Company. The registered enrollment target is 29 participants.
The verdict
NCT03063047, a NA study, has completed, sponsored by RAI Services Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
This study will evaluate exposure to "tar" and nicotine from two menthol cigarette products and provide a basis for comparing mouth-level exposure when smokers smoke the two cigarette products. Mouth-level exposure is the measurement of substance trapped in the cigarette butt after smoking the cigarette. Other purposes of this study are to: * Compare the plasma cotinine, a byproduct of your body's processing of nicotine, levels found in users after smoking each of two different cigarettes. * Find out the daily mouth-level exposure to cigarette "tar" and nicotine from smoking each of two different cigarettes in adult smokers. * Determine if certain measures of nicotine dependence change based on the type of cigarette smoked * To compare product liking and intent to use it again.
Interventions
- OTHER PD21871AA
- OTHER PD21872AA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2017-02-06 |
| Est. Completion | 2017-03-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03063047
The ClinicalTrials.gov registry entry for NCT03063047 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAI Services Company, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PD21871AA is the first listed.
NCT03063047 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03063047 about?
NCT03063047 is a clinical study titled "CSD1603: A Crossover Study to Evaluate the Exposure to "Tar" and Nicotine From 100s Menthol Cigarette Products". This study will evaluate exposure to "tar" and nicotine from two menthol cigarette products and provide a basis for comparing mouth-level exposure when smokers smoke the two cigarette products. Mouth-level exposure is the measurement of substance trapped in the cigarette butt after smoking the cigar...
What is the current status of trial NCT03063047?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2017-02-06. Estimated completion is 2017-03-13.
What interventions are being tested in trial NCT03063047?
The interventions under investigation include: PD21871AA (OTHER), PD21872AA (OTHER).
Who is sponsoring clinical trial NCT03063047?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.